Dosage Study for Vigamox Eye Drops Prior to Intravitreal Injections

Illinois Retina Associates

Status and phase: Completed; Phase 4

Conditions: Intravitreal Injection Patients

Treatments: Drug: Vigamox

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT00690313

Vig508

Details and patient eligibility

About

Antibiotic eye drops are being used before and after intravitreal injections. Currently there is no study indicating the benefit of there usage or their dosage.

In this study we compare the efficacy of Vigamox eye drops (antibiotic)starting 3 days prior to the injection versus 1 day prior to intravitreal injection.

Enrollment: 22 patients

Sex: All

Ages: 21 to 100 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient who need intravitreal injections patients who are willing to participate in the study

Exclusion criteria

• Patients who are allergic to Vigamox or who have taken any eye drops within the past 3 weeks

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

22 participants in 2 patient groups

Arm 1

Active Comparator group

Description:

Arm 1: receives Vigamox eye drops 3Xday for 3 days prior to intravitreal injection

Treatment:

Drug: Vigamox

Arm 2

Active Comparator group

Description:

Arm 2: receives Vigamox eye drops 3Xday for 1 day prior to intravitreal injection

Treatment:

Drug: Vigamox